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Abstract 
Background 
Pathogens have represented an important selective force during the adaptation of 
modern human populations to changing social and other environmental conditions. The 
evolution of the immune system has therefore been influenced by these pressures. 
Genomic scans have revealed that immune system is one of the functions enriched with 
genes under adaptive selection. 
Results 
Here, we describe how the innate immune system has responded to these challenges, 
through the analysis of resequencing data for 132 innate immunity genes in two human 
populations. Results are interpreted in the context of the functional and interaction 
networks defined by these genes. Nucleotide diversity is lower in the adaptors and 
modulators functional classes, and is negatively correlated with the centrality of the 
proteins within the interaction network. We also produced a list of candidate genes 
under positive or balancing selection in each population detected by neutrality tests and 
showed that some functional classes are preferential targets for selection. 
Conclusions 
We found evidence that the role of each gene in the network conditions the capacity to 
evolve or their evolvability: genes at the core of the network are more constrained, 
while adaptation mostly occurred at particular positions at the network edges. 
Interestingly, the functional classes containing most of the genes with signatures of 
balancing selection are involved in autoinflammatory and autoimmune diseases, 
suggesting a counterbalance between the beneficial and deleterious effects of the 
immune response. 
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Background 
 
Infectious diseases are among the most important selective agents for any 
vertebrate species. In humans, they have represented a great challenge in our adaptation 
to new environments and social practices, with increasing population densities sustained 
by improved agricultural technologies and cattle domestication favoring their 
emergence and spread in the last ten thousand years. The human immune system seems 
likely to have played a key role in the adaption of the different populations to changing 
conditions and emerging infections. This hypothesis is supported by recent genomic 
scans for signatures of adaptive selection in human populations showing that immune 
function is one of the classes enriched with genes under positive or balancing selection 
[1-6], the two evolutionary forces underlying adaptation. The literature includes a large 
collection of human genes related to the host-pathogen interaction with signatures of 
adaptation [7, 8]. Vertebrate immune function can be divided into the adaptive, 
exclusive of this phylogenetic group, and the ancient innate immune system, common to 
most multicellular organisms. Innate immunity constitutes the first barrier of defense, 
and acts in a semi-specific way by recognizing pathogen-associated molecular patterns 
(PAMPs), which are essential and conserved components of the pathogens. Substantial 
evidence of positive or balancing selection acting on some of these genes has been 
reported [9-15]. 
In this manuscript, we address the analysis of the footprint of the adaptive 
selection in the innate immune mechanisms involved in (mostly) antibacterial host 
defense. Bacteria have probably been the most important human pathogens, with a 
major impact on morbidity and mortality. Although some of the pathways described 
here are also involved in host defense against human parasites, fungi and viruses, the 
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pattern recognition receptor (PRR) gene families analyzed (TLRs and NLRs) are the 
most important for non-adaptive recognition of bacteria. The other two major classes of 
PRR gene families involved in the host defense to fungi (C-type lectins) and viruses 
(RiG-I helicases) are not included in the present study. 
There is an increasing interest in characterizing the evolutionary dynamics of 
proteins in the context of their functional network. Published data on biological 
networks, for example in the form of experimentally derived data sets of protein-protein 
interactions, or curated databases of functional pathways, have facilitated studies 
relating evolutionary parameters (mainly the footprint of natural selection) to network 
topology [16-19]. We use molecular signatures in particular genes to explore adaptation 
of the functional network, seeking whether human adaptation at the molecular level of 
the innate immunity system has occurred preferentially on some functional class or 
classes (with more plasticity to respond to the pathogenic pressures) or in specific 
positions of the network structure. The final goal of this work is to unravel past selective 
forces that have shaped human immunological responses to bacterial infections having 
acted in humans; the approach is based on detecting adaptations through natural 
selection uncovered in resequencing information in two populations (Europeans and 
Africans). The results are interpreted in the functional context of gene products 
interacting in well-identified networks.  
 
Methods 
 
Selection of genes and DNA sequences 
We included in the study as many genes as possible involved in innate immunity 
with available resequencing data. Data for 132 genes were retrieved from different 
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sources. Sixty-two genes were from the Innate Immunity Program in Genomics 
Applications (IIPGA, http://innateimmunity.net) [20], only considering those genes with 
available information on the sequencing primers used. In addition, data for seven genes 
was obtained from Environmental Genome Project database (NIEHS SNPs, 
http://egp.gs.washington.edu), and for 54 from the SeattleSNPs database 
(http://pga.gs.washington.edu). All sequence data available, both from coding and 
noncoding regions, was included in the analysis. For the analysis, we also included the 
previously published results [11] for eight additional genes from Innate Immunity 
Program in Genomics Applications and one from the SeattleSNPs database. Genes were 
classified according to their function into a comprehensive functional network (Figure 
1). Chimpanzee sequences (panTro2) were obtained from GenBank 
(http://www.ncbi.nlm.nih.gov/) and Ensembl database 
(http://www.ensembl.org/index.html) to be used as outgroups. For IL1F7 we used as 
outgroup the sequence from Pongo pygmaeus from the Ensemble database. Sequence 
alignments were performed with ClustalW [21]. Divergence estimations were retrieved 
from BioMart database (http://uswest.ensembl.org/biomart/index.html), only for 
unequivocal 1-to-1 hits to functional sequences. dN / dS values correspond to the 
comparison of humans and Pan troglodytes for all genes except TLR5 and IL1F8 
(Gorilla gorilla) and IL1F7 (Pongo pygmaeus). 
All included genes from the Innate Immunity Program in Genomics 
Applications, and 44 from SeattleSNPs were resequenced in the same 23 European-
American and 24 African-American samples included in the Coriell CEPH / African 
American panel (Coriell Institute for Medical Research, Camden, NJ). The remaining 
11 genes from Seattle SNPs were resequenced in 23 European (HapMap CEU) and 24 
African individuals (HapMap YRI) individuals. For the seven genes from the 
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Environmental Genome Project database we retrieved resequencing data in 22 European 
(HapMap CEU) and 15 Coriell African American individuals.  
 
Molecular Data Analysis 
The following diversity statistics and neutrality tests were calculated for every 
gene: heterozygosity or π [22], Tajima’s D [23], Fu and Li’s F*, D*, F and D [24] and 
the normalized Fay and Wu’s H tests [25] using DnaSP v5 [26] and MANVa [27]. 
Indels and triallelic positions were not included in the analyses. Genes with less than 
five segregating sites (MYD88 in Africans; MYD88, IL5 and TLR3 in Europeans) where 
not considered in the neutrality tests analysis. COSI software [28] was used to calculate 
the significance of neutrality tests by means of coalescent simulations, using the model 
which takes into consideration the demographic history of humans. COSI produces data 
that closely resembles empirical data from African American, West African and 
European populations. 1,000 replicates were performed by using the local 
recombination rate estimate of each region obtained from HapMap (www.hapmap.org). 
In the case of C3 and ITGA8 it was not possible to run the simulations because of its 
length and high recombination rate. The excess of genes in a given functional class 
under positive, balancing or both selection was tested by means of Fisher’s Exact test in 
a two by two table including: the number of genes in this particular functional class 
under selection, the number of genes in this particular functional class without 
evidences of selection, the number of remaining genes (not in this functional class) 
under selection, and the number of remaining genes (not in this functional class) without 
evidences of selection. 
 
Network analysis 
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 We used the MiMI plugin [29] for Cytoscape [30] to retrieve all known 
interactions for the genes in our dataset. Specifically, we queried the database with the 
132 gene identifiers to retrieve all known protein-protein interactions among those gene 
products and their first neighbors. Network statistics were calculated using the 
NetworkAnalyzer plugin [31] in Cytoscape. 
 
Results 
 
Gene Selection 
We have analyzed publicly available resequencing data for 132 genes involved 
in antibacterial innate immunity in individuals of African and European ancestry (see 
Methods). 129 genes are autosomal and only three genes (IRAK1, TLR7 and TLR8) are 
located in the X chromosome. All these genes have an unequivocal role in host defense 
against bacteria, with some of them also related to immune response against other 
pathogens, and were classified according to their main function in this system into five 
categories: receptors, adaptors, modulators, cytokines and effector molecules (Figure 1). 
We have also defined subclasses in the case of the pattern-recognition receptors (TLR2, 
TLR4, TLR5, NOD1, NOD2, TLR3 and TLR7-9 modules), which can be differentiated 
according to their location in the cell membrane (the first three), in the cytoplasm 
(NOD1 and NOD2), or in endosomes (TLR3, TLR7-9). Cytokines have been 
subclassified according to their involvement in different immune processes (acute 
phase, cellular immunity, anti-inflammatory cytokines, neutrophil function, 
chemokines, and defense against extracellular bacterial parasites). Several genes were 
included in a certain cytokine functional module due to their crucial role for the 
induction of the respective cytokine (e.g. STAT3 gene was included in the Th1 module) 
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or for the role played in the function of the respective cytokine (e.g. JAK3 in the Th1 
module). Five genes were not included in any of the functional classes defined 
(Additional file 1, Table S1). 
 
Nucleotide diversity within a network approach 
 Nucleotide diversity levels can provide a measure of the degree of conservation 
of the different genes and their comparison across functional classes may shed light on 
different intensities of purifying selection. We estimated the nucleotide diversity 
measured as the average number of differences between pairs of sequences (π) for the 
132 genes within each population, and analyzed this information in the context of the 
position of the genes in the functional network and through the comparison of diversity 
levels among the five functional categories defined (see above). 
We obtained the network for all the genes included in the study considering all 
known interactions among the 132 gene products, obtained from the MiMI database for 
molecular interactions (see Materials & Methods). Interactions could be retrieved for 
126 of the 132 genes, and the final network consisted of 1,561 proteins with a total of 
13,002 interactions. A finding emerging from previous studies on the influence of 
network topology on evolutionary rate is the observation that highly connected proteins 
in the protein-protein interaction network (“hubs“) are more constrained in their 
evolution in respect to peripheral ones [32]. Furthermore, proteins in the periphery of 
the interactome have been shown to be more likely to be under positive selection in the 
human lineage than more centrally located ones [17]. In order to test whether this trend 
can also be observed among the innate immunity proteins in our dataset, we investigated 
the correlations between nucleotide diversity and two measures of the centrality of 
nodes within a network: the degree centrality (defined as the total number of links 
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incident upon a node) and the betweenness centrality (defined as the fraction of all 
shortest paths that pass through a node). For these analyses, we considered all known 
interactions within the entire interactome for each of our 126 genes present in the MiMI 
database (see Methods), as they more accurately reflect a particular protein’s position in 
the network than merely considering all interactions among themselves only. 
Significant negative correlation values were obtained for degree centrality with 
nucleotide diversity in Africans (τ = -0.2, P = 0.001) and Europeans (τ = -0.19, P = 
0.002) (Additional file 1, Figure S2). For betweenness centrality and nucleotide 
diversity the correlations were also negative and marginally significant (τ = -0.12, P = 
0.05 for Africans; τ = -0.11, P = 0.08 for Europeans). When only the coding sequence is 
considered these correlations remain significant only in the case of degree centrality in 
Africans (τ = -0.15, P = 0.015) (Additional file 1, Figure S3), probably as a result of 
lack of power given the much smaller number of segregating sites. We repeated these 
analyses comparing both centrality indexes to divergence, measured as the ratio 
between nonsynonymous and synonymous changes (dN/dS) between humans and 
chimpanzees for each gene. Again, the correlations are negative and significant for 
degree centrality (τ = -0.16, P = 0.01) and marginally significant for betweenness 
centrality (τ = -0.12, P = 0.05) (Additional file 1, Figure S4), which is consistent with 
previous results, even though we are restricting our analyses to much fewer genes. 
An alternative approach to the network analysis can be applied by considering 
the hierarchical structure of innate immunity signaling from a functional perspective. 
Figure 1 shows a “bow-tie” shaped organization in terms of the number of components 
and the flow of information: a relatively large number of receptor molecules 
recognizing different classes of pathogens all signal to a limited number of intracellular 
adaptor proteins which, in turn, can interact with proteins that act as modulators, and 
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subsequently signal to a diverse array of downstream molecules, including cytokines 
and other effector molecules (Figure 1). This bow-tie structure characterized by a large 
number of “inputs”, a relatively small number of central control nodes which elaborates 
the information, and a large number of “outputs”, seems to be a topological organization 
widely adopted by metabolic networks [33-35] and also by the immunity system 
signaling network [36]. 
Given this structure, one can hypothesize that the amount of gene variation 
should follow a similar pattern to the one obtained in the context of the position of the 
genes in the network, with the adaptors common to all different pathogen responses 
being more constrained than both up- and downstream proteins, as previously reported 
[33]. Table 1 shows the average value of nucleotide diversity observed in the different 
functional classes, both using the whole sequence and only the coding sequence. 
Adaptors and modulators show significantly lower diversity values. When the whole 
available sequence for the gene is considered, adaptors show lower values of nucleotide 
diversity that are significant in Africans (unpaired t-test P = 0.01) although not in 
Europeans (P = 0.09). Considering only the coding sequence, this difference is 
significant in Africans for the adaptors (P = 0.006) and the modulators (P = 0.05). We 
also used a permutation procedure to test this hypothesis, where the mean nucleotide 
diversity calculated for each defined functional category in the original data is compared 
to 10,000 replicates with class labels randomly permuted. Significance is reached in 
adaptors for Africans (P = 0.004) and Europeans (P = 0.03) when using the whole 
sequence, and for adaptors in Africans for the coding sequence (P = 0.04) (Additional 
file 1, Figures S5 and S6). We repeated this analysis for molecular divergence and, 
although the adaptors and modulators also show the lowest dN / dS values among the 
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five main functional categories, these differences were not statistically significant 
(Additional file 1, Table S2). 
 
Some functional classes are preferential targets for adaptive selection 
We evaluated if some functional categories are also preferential targets for 
positive or balancing selection. We performed six different neutrality tests (see 
Methods) to detect genes with an excess of rare or intermediate variants, which after 
correcting for demographiy can suggest positive or balancing selection. Tajima’s D and 
Fu and Li’s D* and F* use the intraspecific variation data only, whereas Fu and Li’s D 
and F and the normalized Fay and Wu’s H tests compare these intraspecific information 
to a sequence from another species (outgroup). Tajima’s D, and Fu and Li’s D* and F* 
tests are based on the comparison of low frequency variants (Tajima’s D) or singletons 
(Fu and Li’s D* and F*) to intermediate variants. Fu and Li D and F tests are based on 
the comparison of mutations in the external branches of the genealogy to the total 
number of mutations and to the average number of nucleotide differences between pairs 
of sequences, respectively. In these five tests, values lower than expected under 
neutrality are obtained when there is an excess of rare variants (low frequency, 
singletons, mutations at external branches), and values higher than expected under 
neutrality are obtained when there is an excess of intermediate frequency variants. Fay 
and Wu’s H and its normalized test have been proven to have power to detect the 
selective sweeps increasing the frequency of the derived alleles (those different to the 
allele in the outgroup species) produced by positive selection or initial stages of 
balancing selection [25]. The significance of these tests was evaluated by comparing the 
results for each gene to the rest of the genes included in the study (Figure 2), since all 
the sequences are supposed to share the same demographic history. We considered a 
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gene to show evidence of positive or balancing selection if it was included in the 95th 
upper or lower percentiles for two or more neutrality test in the same population. 
Additionally, for those genes statistical significance was also assessed by means of 
coalescent simulations that resemble the demographic history of Africans and 
Europeans (see Methods) (Additional file 1, Table S3). These methods should exclude 
the possibility of these signals being produced randomly or by demographic events such 
as expansion or population contractions. Moreover, our aim is to identify different 
selective pressures acting on the different functional classes, rather than describing 
unequivocal signatures of selection in a particular gene. These possible random effects 
of demography in a particular gene are also minimized by pooling together the genes in 
the same functional class, as we did for the subsequent analysis. 
Table 2 shows the list of candidate genes for positive and balancing selection in 
each population. Coalescent simulations corroborated the results in all cases, with all the 
genes showing significant results in at least two of the neutrality tests (Additional file 1, 
Table S3). Although the neutrality tests used have more power to detect positive rather 
than purifying selection [37] we have indicated among the genes under positive 
selection those with significant results in the Fay and Wu’s H test as genes with 
unequivocal signatures of positive selection (Table 2). From the total of 132 genes, 31 
show signs of adaptive selection: 17 of positive selection (8 in Africans and 10 in 
Europeans, with MPO in the two populations) and 14 of balancing selection (9 in 
Africans and 10 in Europeans, with LY96, IL18RAP, IL1F5, IL1F7 and C3 in the two 
populations). Some of them have been previously reported by independent studies using 
the same or similar datasets: balancing selection in IL1F5, IL1F7, IL1F10 and IL18RAP 
[13] and positive selection in the TLR1-TLR6-TLR10 region finally attributed to TLR1 
[38]. It has to be noted that IL1A, IL1F7, IL1F5 and IL1F10 are located in a region 
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spanning 300 kb at chromosome 2. As discussed in Fumagalli et al [13], it seems 
improbable that a hitchhiking effect is producing all these signatures even between the 
closest genes (IL1F5 and IL1F10), given the low LD and presence of recombination 
hotspots in this region, as well as the fact that balancing selection signatures have been 
proven to spread only over small regions. Moreover, other genes included in this region 
(IL1B, IL1F9, IL1F6 and IL1F8) did not show excess of intermediate variants. 
Beyond signatures of adaptive selection on specific genes, we have analyzed the 
effect of functional classes. Figure 2 shows the results of the six neutrality tests 
performed. We tested for an excess of candidate genes under positive or balancing 
selection (or both) in each functional class, by comparing the number of genes with and 
without significant evidence of adaptive selection in this class against the rest of the 
genes included in the study (see Materials and Methods). Genes with statistical evidence 
for positive or balancing selection are not randomly distributed among the different 
functional classes, and tend to accumulate in a reduced number of classes. Specifically, 
there is an unexpected high number of acute phase proteins showing signatures of 
balancing selection, both in Africans and Europeans (Fisher’s exact test P = 0.03 and 
0.008, respectively). This excess of genes under balancing selection in this functional 
category remains statistically significant even if IL1F5 and IL1F10 signatures in 
Europeans are considered to be produced by the same selective event (P = 0.03). 
Remarkably, all genes in that category with signatures of balancing selection in both 
Europeans and Africans are included in the IL1 or TNF family (Figure 1). Moreover 
MEFV also shows an excess of intermediate variants in one of the neutrality tests in 
Europeans, and signatures of balancing selection have been previously reported [12, 
13]. The complement proteins also show a significant enrichment for genes under 
balancing selection in Africans (Fisher’s exact test P = 0.01). Finally, the receptors are 
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also overrepresented among the genes showing signatures of positive or balancing 
selection, suggesting adaptive selection events. In this case, this tendency is only 
observed in Europeans (Fisher’s exact test P = 0.04), and is due to an excess of 
extracellular receptors (Fisher’s exact test P = 0.02). 
 
Discussion 
A high number of genes analyzed here have showed signs of adaptive selection. 
Even if data is not comparable to whole genome scans looking at the footprint of 
positive selection with SNP data, the five studies published so far [2-4, 6, 39] all 
reviewed in [40] find from 444 to 1,030 genomic regions as candidates for positive 
selection, which represents a very small fraction of the genome (< 4%). Thus our results 
support previous evidence that immunity genes have likely been preferential targets of 
recent adaptive selection in human populations. The excess of genes under adaptive 
selection is still more striking when balancing selection is considered. Balancing 
selection has traditionally been considered to have acted less frequently on human 
populations, and the number of reported cases is smaller in comparison to positive 
selection. However, this difference could be at least partially due to the intrinsic 
difficulties presented by its detection [1]. 
Scientific literature contains several examples of host-pathogen interaction genes 
with evidences of balancing selection. In addition to some well known cases as the 
human major histocompatibility complex, more recently several works have described 
the action of balancing selection on additional immunity genes [10-14, 41-43] and blood 
group antigen genes that are supposed to act as molecular targets for pathogens [12, 13, 
43-45]. The first genome scan for signatures of balancing selection has also confirmed 
an enrichment of immune system and host-pathogen interaction related genes [1]. 
 15
The high number of immunity genes that are under balancing selection is 
presumably due to a beneficial effect in infections, that is counterbalanced by 
deleterious effects in autoinflammatory and autoimmune conditions (Figure 3) [11]. The 
IL-1 family is overrepresented (most abundantly and strongly under balanced selection, 
with 6 genes represented in both European and African populations). Additionally, 
signatures of balancing selection have also been reported in the Mediterranean Fever 
gene, MEFV, another member of this family [12, 13]. There are also members of the 
complement (three genes) and the TNF family (TNFβ/LTα) showing signatures of 
balancing selection. While their role in host defense is well documented, these genes 
encode the main proinflammatory mediators of the two most important classes of sterile 
inflammation disorders: the autoinflammatory diseases (e.g. Crohn’s disease, gout, 
autoinflammatory syndromes, Behcet’s disease) in which inflammation is mediated by 
the IL-1 family, and the autoimmune diseases (e.g. rheumatoid arthritis, systemic lupus 
erythematous, type 1 diabetes) in which the TNF family and complement play a central 
role [46]. Alternatively, variants found at genes under balancing selection could be 
conferring susceptibility to different pathogens and their effect on autoimmunity would 
be a consequence of past humans adaptations, as suggested recently for IFIH1, a innate 
immunity gene involved in resistance to virus [15]. The fact that some of the genes 
found to be under balancing selection are exactly those encoding the major mediators of 
human autoinflammatory and autoimmune pathologies is relevant. 
The dissection of the innate immune system presented here allows inferring 
other important biological consequences. Selection signatures at receptor genes support 
the major evolutionary flexibility described in extracellular TLRs compared to the 
intracellular ones [38, 47]. One important question that may be also asked is which 
major class of bacteria could have exerted the evolutionary pressures observed here. As 
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the innate immune system is relatively non-specific, any genetic information obtained in 
the present study cannot refer to specific species or even families, but rather to broad 
groups of pathogens: both Gram-positive bacteria (e.g. Staphylococci and Streptococci, 
mycobacteria) and Gram-negative bacteria (Salmonella and other enterobacteriaceae, 
Yersinia pestis) contain pathogens that had a major impact on human populations during 
history. An answer to the question of whether both these two groups of bacteria exerted 
evolutionary pressures cannot be obtained from the selection profile of effector genes 
such as defensins or cytokines, as these proteins are generally necessary for host defense 
to both Gram-positive and Gram-negative bacteria. In contrast, a certain level of 
specificity of the innate immune response can be seen by the recognition of either 
Gram-positive bacteria mainly by the TLR2/TLR1/TLR6/TLR10 cluster, while Gram-
negative bacteria recognition is heavily reliant on the TLR4 pathway [48]. In our study 
we found signatures of selection in genes from both the TLR2 cluster (TLR2, TLR6, 
TLR10) and the TLR4 pathway (LY64, LY96, CD14), suggesting that both Gram-
negative and Gram-positive bacteria have exerted pressure on innate immunity genes. In 
addition, TLR9, a pathogen recognition receptor recognizing unmethylated DNA from 
both Gram-negative and Gram-positive bacteria [49] showed also signatures of selection 
in Europeans. The exclusive positive selection of TLR9 and TLR10 (or TLR1) pathways 
in Europeans may be related to more recent responses that could have been related to 
the introduction of agriculture and zoonotic diseases (e.g. Brucella, Coxiella) or the 
major epidemics of the medieval periods (e.g. Yersinia pestis causing pandemics 
including pneumonic, septicaemic and bubonic plague). However, at this point one also 
has to be aware that some of these receptors have also a role for recognition of other 
types of pathogens (e.g. TLR9 for recognition of DNA from certain viruses or parasites, 
or TLR2/TLR4 recognizing also malaria and fungal structures) and although these are 
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secondary recognition pathways for these microorganisms, one cannot exclude 
evolutionary pressures of non-bacterial pathogens on some of the genes analyzed here. 
 
Conclusions 
Overall, our results suggest that the innate immune system has had enough 
plasticity to play an important role in the adaptation of modern humans to new 
environments. Analysis of the protein-protein interaction network suggests a structural 
and functional constraint on genes that occupy a central position in the innate immunity 
network. This network is organized into a bow tie structure, consisting in a large 
number of receptors, a central small number of adaptor genes (the bow tie knot) and a 
large number of effectors. The bow tie structure is already known to characterize many 
metabolic and system networks and it is recognized as a topological feature which 
provides robustness to systems [33, 50]. It also has the advantage of making robustness 
compatible with a high capacity to evolve (or evolvability): the knot provides robustness 
to the system by easily accommodating for perturbations, while a great variability is 
allowed at the edges of the bow tie making possible the generation of new 
functionalities [33]. While the core of the bow tie structure is highly conserved, 
signatures of adaptation are found at the bow tie edges. Therefore, the amount of 
selection acting on each gene appeared therefore highly dependent on its position in the 
network structure. This clearly shows the strength of the constraint represented by the 
topology of the network on the evolution of individual genes, which is able to explain 
much better the adaptive landscape of innate immunity in humans. 
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Figure Legends 
 
Figure 1. Genes included in the study. 
Schematic representation of the function on the innate immune system of the 132 genes 
analyzed in this work. The ligands of the receptors are also showed. 
 
Figure 2. Neutrality tests results. 
Scatter plots for the six neutrality tests performed. Genes in the same functional class 
are represented in the same colors as defined in Figure 1. Cytokines are in green and the 
subcategories are represented by different symbols (filled square for acute phase, filled 
triangle for antiinflamatory cytokines, empty circle for cellular immunity, empty square 
for chemokynes, empty triangle for extracellular, empty inverted triangle for 
neutrophil). For the effector molecules, an empty diamond represents the complement 
category. 
 
Figure 3. Host defense versus autoimmune and autoinflammatory diseases. 
Model representing the counterbalanced effect of host defense against pathogens on the 
one hand, and the deleterious effects of an exaggerated immune response in 
autoimmune and autoinflammatory disease on the other hand. 
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Table 1. Nucleotide diversity in the different functional classes. 
Category N π AFRa 
(× 10 -4) 
π AFR 
CDSb 
(× 10 -4) 
π EURa 
(× 10 -4) 
π EUR 
CDSb 
(× 10 -4) 
Receptors 19 9.3 7.1 6.1 4.8 
Adaptors 10 5.7 3.0 4.8 3.2 
Modulators 6 7.9 3.2 6.3 3.4 
Cytokines 69 8.8 5.8 7.2 4.7 
Acute Phase 20 9.8 6.8 8.6 5.9 
Cellular Immunity 10 8.6 4.4 7.0 3.3 
Antiinflamatory Cytokines 10 8.1 4.1 6.3 4.2 
Neutrophil 9 7.5 4.4 6.2 4.3 
Chemokines 14 8.1 6.6 6.4 4.9 
Extracellular 6 10.0 7.5 7.6 3.7 
Effector 23 9.2 6.1 7.1 4.0 
TOTAL 127 8.6 5.6 6.7 4.3 
a Whole sequence. b Coding sequence. 
π, nucleotide diversity (average of pairwise differences). 
N, number of genes included in each category. 
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